FLUORESCENT IN SITU HYBRIDISATION POSITIVE

This adverse event was reported 10 times

These drugs are most commonly taken by patients reporting FLUORESCENT IN SITU HYBRIDISATION POSITIVE:

# Drug Count
0 CARBOPLATIN 2
1 FLUOROURACIL 2
2 FLUOROURACIL CREAM, 0.5% 2
3 NILOTINIB 2
4 PACLITAXEL 2
5 ADALIMUMAB 1
6 ADALIMUMAB-AATY 1
7 ADALIMUMAB-ADAZ 1
8 ADALIMUMAB-FKJP 1
9 BOSUTINIB 1
See all common drugs associated with FLUORESCENT IN SITU HYBRIDISATION POSITIVE

FLUORESCENT IN SITU HYBRIDISATION POSITIVE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 NADOFARAGENE FIRADENOVEC-VNCG 1 0.0019
1 BOSUTINIB 1 0.0001
2 NILOTINIB 2 0.0001
3 MERCAPTOPURINE 1 0.0001
4 ERGOCALCIFEROL 1 0.0000
5 FLUOROURACIL CREAM, 0.5% 2 0.0000
6 FLUOROURACIL 2 0.0000
7 ADALIMUMAB-FKJP 1 0.0000
8 ADALIMUMAB-AATY 1 0.0000
9 PACLITAXEL 2 0.0000
See all drugs enriched for association with FLUORESCENT IN SITU HYBRIDISATION POSITIVE